Optimization in Drug Candidate Selection and Strategy in Early Drug Development, Wen Chyi Shyu, Ph. D. , Bristol-Myers Squibb, NJ, USA.

药物在筛选中的优化以及在早期开发中的策略徐文祺博士， 高级主管， 百时美-施贵宝药业（美国）

youdao

Thomson hopes those cells will help uncover problems early in the drug development process, saving billions of dollars on research and testing.

Thomson希望这些细胞将有助于发现早期药物开发中的问题，从而为研究和测试过程节省数十亿美元的花费。

youdao

While the weakening economy has forced some drug companies to cancel or delay early phase projects, at least one company has seen a growing need for its niche phase I drug development services.

虽然削弱经济已迫使一些制药公司取消或推迟一些临床项目的早期阶段，但至少一个公司已经看到，越来越需要有其特殊的临床一期的药物开发服务。

youdao

His point was that the NIH and the Food and Drug Administration are increasingly able to handle preclinical and early clinical drug development, and that with these first steps taken medicines are more likely to be brought to market by large pharmaceutical companies.

FORBES: Rare Disease Drugs: A $1 Trillion Market?

The high costs of drug development mean that most early investors no longer own big stakes by the time a medicine finally gets to market.

FORBES: End Of An Era: The Last Herper-Langreth Biotech Story

The wave of new drug development in myeloma dates to the late 1990s and early 2000s, when researchers were scouring old treatments for one that might have an impact on the cancer.

WSJ: New Drugs Slow a Fast-Spreading Cancer